Cited by 84Telomeres, Telomerase, and SenescenceGlioma Diagnosis and TreatmentGenetics, Aging, and Longevity in Model Organisms

The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma

Buhl, Juliane L., Selt, Florian, Hielscher, Thomas, Guiho, Romain, Ecker, Jonas, Sahm, Felix, Ridinger, Johannes, Riehl, Dennis +23 more·2019·Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: Pilocytic astrocytoma is the most common childhood brain tumor, characterized by constitutive MAPK activation. MAPK signaling induces oncogene-induced senescence (OIS), which may cause unpredictable growth behavior of pilocytic astrocytomas. The senescence-associated secretory phenotype (SASP) has been shown to regulate OIS, but its role in pilocytic astrocytoma remains unknown. Experimental Design: The patient-derived pilocytic astrocytoma cell culture model, DKFZ-BT66, was used to demonstrate presence of the SASP and analyze its impact on OIS in pilocytic astrocytoma. The model allows for doxycycline-inducible switching between proliferation and OIS. Both states were studied using gene expression profiling (GEP), Western blot, ELISA, and cell viability testing. Primary pilocytic astrocytoma tumors were analyzed by GEP and multiplex assay. Results: SASP factors were upregulated in primary human and murine pilocytic astrocytoma and during OIS in DKFZ-BT66 cells. Conditioned medium induced growth arrest of proliferating pilocytic astrocytoma cells. The SASP factors IL1B and IL6 were upregulated in primary pilocytic astrocytoma, and both pathways were regulated during OIS in DKFZ-BT66. Stimulation with rIL1B but not rIL6 reduced growth of DKFZ-BT66 cells and induced the SASP. Anti-inflammatory treatment with dexamethasone induced regrowth of senescent cells and inhibited the SASP. Senescent DKFZ-BT66 cells responded to senolytic BCL2 inhibitors. High IL1B and SASP expression in pilocytic astrocytoma tumors was associated with favorable progression-free survival. Conclusions: We provide evidence for the SASP regulating OIS in pediatric pilocytic astrocytoma, with IL1B as a relevant mediator. SASP expression could enable prediction of progression in patients with pilocytic astrocytoma. Further investigation of the SASP driving the unpredictable growth of pilocytic astrocytomas, and its possible therapeutic application, is warranted.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-18-1965

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dexamethasone blunts the SASP in models of senescent cancer cells.

    “Dexamethasone is an approved glucocorticoid (Dexamethasone in Hospitalized Patients with Covid‐19—Preliminary Report, 2020) and has been demonstrated to blunt the SASP, albeit in models of senescent cancer cells (Ge et al, 2018; Buhl et al, 2019).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Buhl, J. L., Selt, F., Hielscher, T., Guiho, R., Ecker, J., Sahm, F., Ridinger, J., Riehl, D., Usta, D., Ismer, B., Sommerkamp, A. C., Martinez-Barbera, J. P., Wefers, A. K., Remke, M., Picard, D., Pusch, S., Gronych, J., Oehme, I., van Tilburg, C. M., Kool, M., Kuhn, D., Capper, D., von Deimling, A., Schuhmann, M. U., Herold-Mende, C., Korshunov, A., Brummer, T., Pfister, S. M., Jones, D. T. W., Witt, O., & Milde, T.
Affiliations
  • German Cancer Research Center (DE)
  • University College London (GB)
  • 6Developmental Biology and Cancer Programme, Birth Defects Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.
  • 1Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • 7Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Universitätsklinikum Tübingen (DE)
  • 18Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • University of Freiburg (DE)
Corresponding author
Milde, Till
Venue
Clinical Cancer Research
Published
2019-03-15
Volume
25
Issue
6
Pages
1851-1866
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2903690341
Cited by
84
References
57
Citations by year
2026: 5 · 2025: 11 · 2024: 18 · 2023: 11 · 2022: 14 · 2021: 11 · 2020: 10 · 2019: 3
FWCI
4.11
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
German Research Foundation (Oe542/2-1)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
pilocytic astrocytoma, senescence-associated secretory phenotype, oncogene-induced senescence, MAPK signaling, IL-1β, interleukin-6, dexamethasone, tumor progression prediction, pediatric brain tumors, tumor growth arrest
MeSH terms
Progression-Free Survival, Animals, Astrocytoma, Brain Neoplasms, Child, Disease Models, Animal, Female, Humans, Male, Prognosis, Tumor Cells, Cultured, Cellular Senescence, Culture Media, Conditioned, Gene Expression Profiling, Cell Proliferation, Mice, Interleukin-1beta, Primary Cell Culture, Datasets as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review